Project Description

Vindrauga Holdings, LLC, dba Ridge Dx Labs has developed multi-variant biological marker assays and diagnostic algorithms to diagnose, select and monitor treatment for MDD and other neuropsychiatric disorders.

Ridge Dx Labs is a neurodiagnostic company offering its proprietary first-in-class blood test for Major Depressive Disorder (MDD) through its CLIA certified laboratory in North Carolina. Based upon its proprietary Human Biomarker Library and its Biomarker Hyper-Map™ technology platform, Vindrauga has developed multi-variant biological marker assays and diagnostic algorithms to diagnose, select and monitor treatment for MDD and other neuropsychiatric disorders.

Antidepressant drugs are the most frequently prescribed medication in the US today where depression strikes over 19 million adults each year – more than coronary artery disease, cancer or AIDS. For the first time, objective biological test information about depression may aid physicians in the differential diagnosis of MDD, the selection of proper treatment and effective management of their patients.